Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · IEX Real-Time Price · USD
14.31
-0.14 (-0.97%)
At close: Jul 19, 2024, 4:00 PM
14.01
-0.30 (-2.10%)
Pre-market: Jul 22, 2024, 8:50 AM EDT
Olema Pharmaceuticals Employees
Olema Pharmaceuticals had 74 employees as of December 31, 2023. The number of employees decreased by 12 or -13.95% compared to the previous year.
Employees
74
Change (1Y)
-12
Growth (1Y)
-13.95%
Revenue / Employee
n/a
Profits / Employee
-$1,342,419
Market Cap
800.41M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 74 | -12 | -13.95% |
Dec 31, 2022 | 86 | 12 | 16.22% |
Dec 31, 2021 | 74 | 37 | 100.00% |
Dec 31, 2020 | 37 | - | - |
Related Stocks
Company Name | Employees |
---|---|
The Pennant Group | 5,791 |
Atrion | 712 |
Cytek Biosciences | 676 |
Clover Health Investments | 552 |
Standard BioTools | 539 |
Aurinia Pharmaceuticals | 300 |
Simulations Plus | 197 |
Abivax | 61 |
OLMA News
- 19 days ago - Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Olema Oncology to Participate in Upcoming Investor Conferences in June - GlobeNewsWire
- 2 months ago - Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presented at the 2024 ESMO Breast Cancer Congress - GlobeNewsWire
- 2 months ago - Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress - GlobeNewsWire
- 2 months ago - Olema Oncology to Participate in Upcoming Investor Conferences in May - GlobeNewsWire
- 3 months ago - Olema Oncology to Participate in Canaccord Genuity 2024 Horizons in Oncology Virtual Conference - GlobeNewsWire
- 4 months ago - Olema Oncology Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire